This HTML5 document contains 202 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n10http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q64935839
rdf:type
wikibase:Item
schema:description
tieteellinen artikkeli 2018年の論文 vitenskapelig artikkel научни чланак мақолаи илмӣ vedecký článok artigo científico מאמר מדעי наукова стаття, опублікована в грудні 2018 2018年學術文章 vitskapeleg artikkel scienca artikolo artikull shkencor articol științific article scientific 2018年學術文章 научна статия 2018年学术文章 artikel ilmiah artículu científicu scientific article published on 3 December 2018 tudományos cikk vetenskaplig artikel 2018年学术文章 2018년 논문 teaduslik artikkel 2018 nî lūn-bûn artigo científico 2018年学术文章 article científic wissenschaftlicher Artikel 2018年學術文章 wetenschappelijk artikel scientific article published on 3 December 2018 مقالة علمية نشرت في 3 ديسمبر 2018 articolo scientifico vědecký článek სამეცნიერო სტატია 2018年学术文章 artigo científico บทความทางวิทยาศาสตร์ bilimsel makale ৩ ডিসেম্বর ২০১৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ научни чланак 2018年學術文章 2018年学术文章 artículo científico publicado en 2018 naučni članak artikulong pang-agham videnskabelig artikel udgivet 3. december 2018 2018年學術文章 επιστημονικό άρθρο artykuł naukowy bài báo khoa học научная статья 2018 թվականի դեկտեմբերի 3-ին հրատարակված գիտական հոդված 2018年学术文章 scientific article published on 3 December 2018 article scientifique
p:P577
wds:Q64935839-37089622-2E88-4E5B-8D12-77FF2A0207E7
wdt:P577
2018-12-03T00:00:00Z
p:P2860
wds:Q64935839-A782E977-CE4C-48DC-989B-D8AD90C0BC6E wds:Q64935839-A89B1F3F-2A3D-47DC-AE0F-F79F32E02F58 wds:Q64935839-923883A5-C80B-4335-9367-300959846D8A wds:Q64935839-944B7B8E-2317-4D33-A79F-4FFA8E9981B8 wds:Q64935839-8A8F006A-58D7-41B6-8D9E-09B125512A9D wds:Q64935839-8B5A65C7-00BF-46AB-9A72-6F1479AC5557 wds:Q64935839-758AE979-72CD-49B0-91D7-1B4A99DBDD31 wds:Q64935839-8444D8EA-AF3A-42EC-ADC3-520D4E9A4D41 wds:Q64935839-69B71E1E-DAD3-4A59-AFC1-2FEE7BA63F02 wds:Q64935839-6A5712C9-4538-4912-9E9F-F1FB0916A4FB wds:Q64935839-46F102BA-2C61-45C3-831C-DE9EC3325C8E wds:Q64935839-4A3B3B67-1DF8-4E04-9297-AE93B0B6312F wds:Q64935839-5C149EB9-2D4E-4549-8691-B72C688E9FE5 wds:Q64935839-F7ECB60C-F7A5-48BF-A9D3-C3D70FB49B15 wds:Q64935839-F885700F-3412-475A-9F65-63CC9033A448 wds:Q64935839-F017A049-53FB-4FD1-9BCD-7FEDF2129514 wds:Q64935839-F4CBA45B-7A7B-49A5-A841-F5A4B6EC1C86 wds:Q64935839-F6AB6119-A2F3-4007-9721-C28301C116A7 wds:Q64935839-C8AB5B62-B155-43B2-A11E-3C27FB938458 wds:Q64935839-CD52D775-4854-4E78-974F-24CB690DD6D1 wds:Q64935839-D30DAAA3-57E3-4A80-AD13-103A80EA24CC wds:Q64935839-D4E96D5A-E75A-40F2-BE4A-526E7B13E695 wds:Q64935839-C164DE6F-B1FC-48AA-9DAF-9BAAA9B4414D wds:Q64935839-335E44AC-1B2E-4F59-9EE4-0F778296F7FD wds:Q64935839-33C57819-CA49-4F4F-92CA-3E23B2F604AE wds:Q64935839-33FE3A8E-FA92-4E92-80B7-69EB1599DC64 wds:Q64935839-365A9547-2027-4EF1-A1CE-634585895AB9 wds:Q64935839-2133F6F2-CA14-4D8E-9845-5A655A1E18D4 wds:Q64935839-2C5F2E85-B42E-4FF1-86F2-BA13C341F702 wds:Q64935839-310B3ACF-7542-4454-9118-0CC8F007E357 wds:Q64935839-196F37C3-AEE1-4202-97EF-BBCCEC8F30A0 wds:Q64935839-0269FD3D-D4EB-49E1-831C-64F470B1979C wds:Q64935839-10D4D012-4AEE-416B-859E-D1B50CD7A54A wds:Q64935839-A949AC70-1C5C-450D-84D5-10B61E6C1359 wds:Q64935839-B440A209-B7B1-4952-A03F-5C513B4B3037 wds:Q64935839-B675B3B0-2661-4746-BBB0-778B3FA2F633
wdt:P2860
wd:Q30410163 wd:Q42775676 wd:Q38597700 wd:Q41139015 wd:Q29617568 wd:Q29547407 wd:Q40385205 wd:Q46796397 wd:Q33441143 wd:Q47399678 wd:Q48342416 wd:Q37531434 wd:Q39291912 wd:Q27860910 wd:Q39161484 wd:Q29620127 wd:Q33990834 wd:Q33427367 wd:Q41250426 wd:Q39160279 wd:Q38909395 wd:Q36179190 wd:Q27345024 wd:Q34276149 wd:Q48271471 wd:Q38785510 wd:Q33710967 wd:Q48865058 wd:Q56336747 wd:Q33416502 wd:Q34645665 wd:Q87852033 wd:Q46942082 wd:Q30661157 wd:Q29617585 wd:Q57291646
p:P2093
wds:Q64935839-5D873AF0-F542-4192-A054-F7D0AC6E1058 wds:Q64935839-63DB401D-926B-4337-B52E-B0456E1778B0 wds:Q64935839-83D07E50-42AA-4C4E-9BF8-565B29DEE24D wds:Q64935839-3A6729E7-CF34-4285-B1C0-E32DE13CEE00 wds:Q64935839-41C2806E-222F-415D-A7F2-B88CEF82DEDA wds:Q64935839-4BC3EED8-6E36-488B-A1F2-3D671F7A3CF8 wds:Q64935839-ADC6DB61-1B37-479D-B959-82D63FAB88B5 wds:Q64935839-8C577DE9-B426-4310-B7F8-6D55C80AE734 wds:Q64935839-9DB08B18-738D-4052-BA12-E9E128436B72 wds:Q64935839-27BF57C3-9558-4EE9-957A-57FBE3946A32 wds:Q64935839-18BC2A19-7EFC-4F66-8CC2-1D201D304FA2 wds:Q64935839-E08974C5-856C-4A06-9960-783AE9256717 wds:Q64935839-D8B105A1-95D5-4BFF-9C4F-7DE16E4D1D4F wds:Q64935839-F4E434AB-54B5-4DA0-B5C2-B458F9D95E85 wds:Q64935839-B7B2933D-69F7-4AB2-B6B5-176192590CB1 wds:Q64935839-FD34F4A2-AA53-41F0-940C-B9AA8099A8A8
wdt:P2093
Ardi Pambuku Marina Paola Gardiman Simona Rizzato Riccardo Soffietti Giovanna Magni Bruno Daniele Francesco Pasqualetti Miriam Farina Alba Ariela Brandes Vittorina Zagonel Marina Faedi Ivan Lolli Luisa Bellu Stefano Indraccolo Giuseppe Lombardi Roberta Rudà
rdfs:label
Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial. Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial.
skos:prefLabel
Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial. Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial.
schema:name
Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial. Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial.
p:P50
wds:Q64935839-01503E1D-32E2-42A2-8BE6-92B195759392 wds:Q64935839-95A02AD5-6FAE-461B-B695-98559D18258D wds:Q64935839-A7553114-2611-4B1D-B702-E28630051D51
wdt:P50
wd:Q43091331 wd:Q72115386 wd:Q77408171
p:P1476
wds:Q64935839-9E998B19-EA63-4407-8172-4082FCFB3600
wdt:P1476
Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial
p:P304
wds:Q64935839-157A8B21-A134-4F49-A9A2-39703BD1B7EA
wdt:P304
110-119
p:P31
wds:Q64935839-8DCA2E3D-5B10-4C83-9FCE-7163461B91A1
wdt:P31
wd:Q13442814
p:P921
wds:Q64935839-7D883E3C-20D7-4AE1-9036-B171419BDFDA wds:Q64935839-12D48253-3ADE-465C-8794-ED0F35F48ABE wds:Q64935839-C1888464-A4E0-4CCB-8FAD-91FA37F01A3A
wdt:P921
wd:Q6934595 wd:Q42824440 wd:Q282142
p:P698
wds:Q64935839-FC72F68F-1905-44A0-89F1-7F0CF4117C7B
wdtn:P698
n12:30522967
wdt:P698
30522967
p:P1433
wds:Q64935839-C6AB9D99-2C7B-4A35-98C4-95DF38D11A26
wdt:P1433
wd:Q13747613
p:P433
wds:Q64935839-37EBD2A1-69D9-41B3-A187-14E6B378F3A6
p:P478
wds:Q64935839-E2D709E9-2DDD-4722-A8F6-58C260A43AC7
wdt:P433
1
wdt:P478
20
p:P356
wds:Q64935839-D609639F-F2FE-4465-961B-841F504E8F02
wdtn:P356
n10:S1470-2045(18)30675-2
wdt:P356
10.1016/S1470-2045(18)30675-2